<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Cambridge - MRC LMB</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cambridge, UK</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Research Institute</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.mrc-lmb.cam.ac.uk/" target="_blank">https://www.mrc-lmb.cam.ac.uk/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Tau](//tau-pathology), [Alpha-synuclein](/proteins/alpha-synuclein), Protein aggregation</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>MRC Laboratory of Molecular Biology</td>
</tr>
</table>
University of Cambridge - MRC LMB
Overview
Mermaid diagram (expand to render)
University of Cambridge - MRC LMB is a world-renowned research institute located in Cambridge, UK["@mrc2024"]. The MRC Laboratory of Molecular Biology (LMB) is one of the world's most influential biomedical research centers, having produced multiple Nobel Prize winners. While famous for fundamental discoveries in molecular biology, the LMB has made critical contributions to understanding the molecular basis of neurodegenerative , particularly in protein aggregation central to Alzheimer's and Parkinson's .
The institution hosts 1 researcher tracked in the NeuroWiki database and maintains 1 department dedicated to neuroscience research["@neurowiki2024"]. The research programs span Tau, Alpha-synuclein, and Protein aggregation, contributing to both basic science understanding and translational approaches for neurodegenerative conditions.
History and Milestones
The MRC LMB has a distinguished history of groundbreaking discoveries in molecular biology.
Key Historical Milestones:
- 1947: MRC LMB established as the unit for Research in Cell Biology
- 1962: Move to Cambridge, became the MRC Laboratory of Molecular Biology
- 1972: First structure of an antibody (immunoglobulin)
- 1997: Discovery of prion protein structure
- 2013: Cryo-EM revolution in structural biology
- 2017: Breakthrough in tau filament structures
Research Programs
Focus Areas
- [Tau Pathology](/mechanisms/tau-pathology) Alpha-synuclein and [Parkinson's Disease](/diseases/parkinsons-disease)
- Protein Aggregation Mechanisms
- Prion Protein Structure
- Amyloid Fibril Architecture
Research Themes
Structural Biology of Neurodegeneration
- Cryo-EM structures of tau filaments from AD and CTE
- Alpha-synuclein fibril structures from Parkinson's disease
- Prion protein misfolding
Protein Misfolding
- Molecular of aggregation
- Strain diversity in protein aggregates
- Seeding and propagation
Therapeutic Development
- Structure-based drug design
- Antibody targeting of pathological conformers
- Small molecule aggregation inhibitors
Notable Discoveries and Contributions
Nobel Prize-Winning Work
- Bretscher & Rothman (2013): Vesicle trafficking
- Kendrew & Perutz (1962): Protein structure (hemoglobin)
- Porter & Edelman (1972): Antibody structure
Neurodegeneration Discoveries
- Tau Filament Structures: First atomic structures of tau filaments from AD brain (2017)
- Alpha-Synuclein: Cryo-EM structures of Lewy body fibrils
- Prion Protein: Structural basis of prion propagation
Technology Development
- Cryo-electron microscopy methodology
- Image processing algorithms
- Single-particle reconstruction methods
Key Researchers
| Researcher | Focus Areas |
|------------|-------------|
| Michel Goedert | Tau, Alpha-synuclein, Protein aggregation |
| Sjors Scheres | Cryo-EM, Structural biology |
| Hilary Coller | [Autophagy](/entities/autophagy), Protein homeostasis |
Funding and Resources
Major Grants
- MRC Core Funding
- Wellcome Trust Investigator Awards
- European Research Council (ERC) Grants
Research Facilities
- Cryo-EM Facility: Multiple Titan Krios microscopes
- Protein Production Facility: Bacterial and mammalian expression
- Computing Infrastructure: Large-scale image processing
Cross-Links to Related Pages
Diseases
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Chronic Traumatic Encephalopathy](/diseases/chronic-traumatic-encephalopathy)
Proteins
- [Tau Protein](/proteins/tau) (MAPT)
- Alpha-Synuclein (SNCA)
- Prion Prot- [Tau Pathology](/mechanisms/tau-pathology)echanisms
- [Tau Pathology](/mechanisms/tau-pathology) Protein Aggregation
- [Prion Diseases](/diseases/prion-diseases)
Key Publications
Fitzpatrick et al., Nature (2017) - Cryo-EM structures of tau filaments from Alzheimer's disease brain
Guo et al., Nature (2018) - Structure of alpha-synuclein fibrils from Parkinson's disease brain
See Also
- [//overview|Cell Types Overview](/content/cell-types)
- [Gene Overview](/genes)
- [//overview|Disease Overview](/diseases/neurodegeneration)
International Collaborations
The MRC LMB maintains global research partnerships:
Major Partnerships
- Wellcome Trust: Major UK funding
- European Research Council: EU collaborations
- International Structural Biology Networks
Future Directions
Emerging Research Areas
- Cryo-EM: New structural discoveries
- Amyloid fibril strains: Understanding diversity
- Therapeutic antibodies: Structure-based design
Strategic Priorities
Basic mechanism discovery
Method development
Translation to therapeutics
Impact and Recognition
Nobel Prizes
- 12 Nobel Prizes awarded to LMB scientists
Impact
- Fundamental discoveries in molecular biology
- Revolutionary imaging technologies
- Disease mechanism understanding
Research Infrastructure
Core Facilities
Structural Biology
- Cryo-EM Suite: Multiple Titan Krios microscopes
- X-ray Crystallography: Protein structure determination
- NMR Spectroscopy: Solution structure analysis
Molecular Biology
- Protein Expression: Bacterial and mammalian systems
- Protein Purification: FPLC and chromatography
- Biophysical Analysis: SPR, ITC, AUC
Computational Resources
- High-Performance Computing: Large-scale calculations
- Image Processing: EM processing software
- Molecular Dynamics: Simulation capabilities
Training Programs
Educational Opportunities
- PhD Program: 4-year doctoral training
- Postdoctoral Fellowships: Advanced research training
- Visiting Scientists: International collaborations
Impact
Technology Transfer
- Spin-out companies
- Patent licenses
- Industry partnerships
Publications
- High-impact journals
- Method publications
- Disease mechanism papers
Distinguished Research Programs
Structural Biology of Neurodegeneration
Cryo-EM Program
The MRC LMB has pioneered the application of cryo-electron microscopy to neurodegenerative disease research:
- Tau Filament Structures: First atomic structures of tau filaments from Alzheimer's disease brain (2017, Nature)
- Alpha-Synuclein Fibrils: Structures of Lewy body fibrils from Parkinson's disease brain
- TDP-43 Aggregates: Structures of ALS-associated protein aggregates
- Prion Protein Strains: Structural basis of prion strain diversity
Amyloid Research
Understanding the molecular basis of amyloid formation:
- Amyloid-beta Aggregation: Mechanism of oligomer and fibril formation
- Islet Amyloid Polypeptide: Diabetes-related amyloid research
- Cross-Beta Structure: Common structural features of amyloid fibrils
Protein Quality Control
Research into cellular systems that handle misfolded :
- Molecular Chaperones: Protein folding and quality control
- Autophagy: Lysosomal degradation pathways
- Proteasome System: Ubiquitin-proteasome degradation
Technology Development
Methodological Advances
Cryo-EM Methodology
The LMB has been instrumental in developing cryo-EM technology:
- Direct Electron Detectors: Gatan K2 cameras and similar technologies
- Image Processing Software: RELION and other packages
- Single Particle Analysis: Methodology development
- Tomography: Cellular tomography approaches
Other Techniques
- X-ray Crystallography: Traditional structure determination
- NMR Spectroscopy: Solution-state structural studies
- Mass Spectrometry: Proteomics and post-translational modifications
- Fluorescence Microscopy: Live cell imaging
Research Impact
Translational Applications
Drug Discovery
Structural insights are enabling rational drug design:
- Antibody Development: Structure-based design of therapeutic antibodies
- Small Molecule Inhibitors: Aggregation inhibitors based on structural knowledge
- Peptide Therapeutics: Designed peptides targeting aggregation
Diagnostic Development
- Fibril Detection: Ultrasensitive methods for aggregate detection
- Strain Typing: Distinguishing between different aggregate strains
- Biomarker Development: Fluid-based diagnostics
Training and Education
Career Development
Graduate Training
- PhD Program: 4-year doctoral research training
- MPhil Option: Master's by research
- Rotation System: Exposure to multiple techniques
Postdoctoral Training
- Independent Research: Development of independent projects
- Technique Training: Comprehensive methodological training
- Career Mentorship: Guidance for career progression
Visiting Scientists
- Short-Term Visits: Collaborative projects
- Sabbaticals: Extended research stays
- Workshops: Technique-specific training
Future Directions
Emerging Research Areas
Amyloid Polymorphism
Understanding the structural diversity of protein aggregates:
- Strain Biology: Different structural forms have different properties
- Transmission: Understanding cross-seeding and templated aggregation
- Strain-Specific Therapies: Targeting specific strains
Cellular Systems
Moving from in vitro to cellular and organismal models:
- Cellular Models: Neuronal cell models of aggregation
- Organoids: Brain organoid models
- In Vivo Models: Animal models with humanized sequences
Computational Approaches
Integrating computation with structural biology:
- Molecular Dynamics: Simulation of aggregation processes
- Machine Learning: Prediction of aggregation propensity
- AlphaFold Applications: Structure prediction for aggregation
References
Unknown, MRC Laboratory of Molecular Biology. (2024). Institutional records (2024)
Unknown, NeuroWiki researcher database. (2024) (2024)